Cytomegalovirus infection does not impact on survival or time to first treatment in patients with chronic lymphocytic leukemia.

Am J Hematol · 2016 · PMC4957613 · PMID 27124884

Europe PMC DOI

hedged sentence

0.1580

closest p · 3.2× alpha

0.1580

boldest claim

The sentences

did not reach statistical significanceP = 0.158not close (p > 0.1)

As noted in the discovery cohort, a shorter median overall survival of 10.6 years was noted in HCMV positive participants (95% CI: 8.4–12.5) compared with 15.9 years (95% CI: 6.9–25.0) in HCMV negative participants although this did not reach statistical significance on either univariate (HR 1.45, 95% CI: 0.86–2.43; P = 0.158) or multivariate analysis (HR 0.96, 95% CI: 0.57–1.63; P = 0.882).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.